ArticleLeukemia2024
ASXL1 mutation is a novel risk factor for bleeding in Philadelphia-negative myeloproliferative neoplasms.
Hassan Awada et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleLeukemia2024
Hassan Awada et al.PubMed ↗Publisher ↗
No numbers read from the abstract.